600511 China National Medicines Corporation Ltd. SSE · China

China National Medicines Corporation (600511) news

China National Medicines Corporation Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600511, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest China National Medicines Corporation news

We have not published a story on China National Medicines Corporation yet. When there is news, it will appear here.

Questions about China National Medicines Corporation

What is the ticker symbol of China National Medicines Corporation?

China National Medicines Corporation Ltd. trades under the ticker 600511 on SSE.

Where is China National Medicines Corporation listed?

China National Medicines Corporation Ltd. is listed on SSE.

Which country or territory is China National Medicines Corporation listed under?

Our directory records China National Medicines Corporation Ltd. under China.

What does China National Medicines Corporation do?

Our directory classifies China National Medicines Corporation Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of China National Medicines Corporation?

The ISIN recorded for China National Medicines Corporation Ltd. is CNE000001D56.

Does aibio.space cover China National Medicines Corporation?

aibio.space lists China National Medicines Corporation Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to China National Medicines Corporation?

Companies in our directory listed in the same country and business area as China National Medicines Corporation: China Pharma Holdings, Nanjing Hicin Pharmaceutical Co., C.Q. Pharmaceutical Holding Co., Staidson (Beijing) Biopharmaceuticals Co., Shandong Lukang Pharmaceutical Co., Luye Pharma Group.

Investor discussion: China National Medicines Corporation

Members talk about China National Medicines Corporation (600511). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600511 on TradingView.

Listing details

Company: China National Medicines Corporation Ltd.
Ticker: 600511
Listing: SSE
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: CNE000001D56
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction